INTRAVENOUS USE OF SALT-POOR HUMAN ALBUMIN - EFFECTS IN 34 PATIENTS WITH DECOMPENSATED HEPATIC CIRRHOSIS

被引：23
|
作者：
POST, J
ROSE, JV
SHORE, SM
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 1951年 / 87卷 / 06期
关键词：
D O I：
10.1001/archinte.1951.03810060002001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 788
页数：14
相关论文
共 50 条
  • [31] Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
    Kuan, Yi-Chun
    Huang, Kuang-Wei
    Lin, Cheng-Li
    Luo, Jiing-Chyuan
    Kao, Chia-Hung
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [32] The albumin-functionality-test (AFT) as a new valuable tool to assess human albumin function and predict ACLF in patients with decompensated cirrhosis
    Waterstradt, Katja
    Baldassarre, Maurizio
    Schnurr, Kerstin
    Antognoli, Agnese
    Zaccherini, Giacomo
    Tufoni, Manuel
    Caraceni, Paolo
    JOURNAL OF HEPATOLOGY, 2020, 73 : S30 - S30
  • [33] Real-world survival outcomes in patients with decompensated cirrhosis receiving long term human albumin infusions
    Hannah, Nicholas
    Tjandra, Douglas
    Patwardhan, Ashwin
    Rutland, Kelsey
    Sood, Siddharth
    JOURNAL OF HEPATOLOGY, 2022, 77 : S622 - S622
  • [34] Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis
    Fernández, J
    Navasa, M
    Garcia-Pagan, JC
    G-Abraldes, J
    Jiménez, W
    Bosch, J
    Arroyo, V
    JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 384 - 390
  • [35] CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis
    Nakamura, Toru
    Torimura, Takuji
    Iwamoto, Hideki
    Kurogi, Jyunichi
    Inoue, Hiroto
    Hori, Yukie
    Sumie, Shuji
    Fukushima, Nobuyoshi
    Sakata, Masahiro
    Koga, Hironori
    Abe, Mitsuhiko
    Ikezono, Yu
    Hashimoto, Osamu
    Ueno, Takato
    Oho, Kazuhiko
    Okamura, Takashi
    Okuda, Seiya
    Kawamoto, Atsuhiko
    Ii, Masaaki
    Asahara, Takayuki
    Sata, Michio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (10) : 1830 - 1838
  • [36] Effects of albumin treatment on cell death markers in patients with decompensated cirrhosis and in acute-on-chronic liver failure
    Alcaraz, Estefania
    Mestre, Anna
    Horrillo, Raquel
    Vidal, Jordi
    Torres, Mireia
    Claria, Joan
    Fernandez, Javier
    Arroyo, Vicente
    Bravo, Isabel
    Costa, Montserrat
    JOURNAL OF HEPATOLOGY, 2024, 80 : S177 - S178
  • [37] IMPACT OF INTRAVENOUS ALBUMIN INFUSION ON 28-DAY MORTALITY AND COMPLICATIONS IN PATIENTS WITH ACUTELY DECOMPENSATED CIRRHOSIS: A PROPENSITY SCORE MATCHING ANALYSIS
    Cao, Zhujun
    Zhang, Chenxi
    An, Baoyan
    Chen, Yaoxing
    Cai, Minghao
    Li Ziqiang
    Qian, Zhuping
    Xin, Haiguang
    Xie, Qing
    HEPATOLOGY, 2024, 80 : S1727 - S1728
  • [38] LONG TERM USE OF PROTON PUMP INHIBITORS INCREASES MORTALITY AND HEPATIC DECOMPENSATION IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
    De Roza, Marianne A.
    Ang, Tiing Leong
    Kwek, Andrew
    Fock, Kwong Ming
    Teo, Eng Kiong
    Hsiang, John C.
    GASTROENTEROLOGY, 2019, 156 (06) : S1189 - S1190
  • [39] THE EFFECTS OF INTRAVENOUS INJECTION OF CONCENTRATED HUMAN SERUM ALBUMIN UPON BLOOD PLASMA, ASCITES AND RENAL FUNCTIONS IN 3 PATIENTS WITH CIRRHOSIS OF THE LIVER
    PATEK, AJ
    MANKIN, H
    COLCHER, H
    LOWELL, A
    EARLE, DP
    JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (01): : 135 - 144
  • [40] INTRAVASCULAR VOLUME OVERLOAD IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ASSOCIATED WITH A LOWER TOLERABILITY OF INTRAVENOUS ALBUMIN AND WORSE OUTCOMES, A SINGLE CENTER, PROSPECTIVE, COHORT STUDY
    Jose-David Prieto, Luis Alejandro Rosales Renteria
    Aguirre-Villarreal, David
    Salcido-Yanez, Cesar
    Sandez-Araiza, Adrian
    Francisco Perez-Roa, Giovanni
    Garcia Juarez, Ignacio
    Gonzalez Huezo, Maria Sarai
    HEPATOLOGY, 2024, 80 : S1735 - S1736
12345